FDA (Drugs) recall action 72028
The FDA (Drugs) publishes a recall like this one as 13 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 13 pages.
Stability Data Does Not Support Expiry
Subpotent Drug
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Cantrell Drug Company is recalling 4,170 syringes of Heparin Sodium in 0.45% Sodium Chloride because stability data does not support the expiration date.
Cantrell Drug Company is recalling 3,853 syringes of Midazolam HCl injection because the drug was subpotent. The recall is voluntary and nationwide.
Cantrell Drug Company is recalling 884 syringes of fentanyl citrate injection because the drug was subpotent. The recall is voluntary and nationwide.
Cantrell Drug Company is recalling fentanyl citrate injection syringes because they contain less active drug than labeled.
Cantrell Drug Company is recalling 352 syringes of Heparin Sodium 0.5 USP UNITS/mL because stability data does not support the expiration date.
Cantrell Drug Company is recalling 212 syringes of Midazolam HCl that may contain less than the labeled amount of active ingredient.
Cantrell Drug Company is recalling 42 syringes of fentanyl citrate injection because the drug was subpotent. The recall is voluntary and nationwide.
Cantrell Drug Company is recalling 148 syringes of fentanyl citrate injection because the drug was subpotent. The recall is voluntary and nationwide.
Cantrell Drug Company is recalling 1,652 syringes of fentanyl citrate because the medication was subpotent. The recall is voluntary and nationwide.
Cantrell Drug Company is recalling 235 syringes of fentanyl citrate injection because the drug was subpotent. The recall is voluntary and nationwide.
Cantrell Drug Company is recalling 1,570 syringes of Midazolam HCl injection because the drug was found to be subpotent. The recall is voluntary and nationwide.
Cantrell Drug Company is recalling specific lots of Atropine Sulfate Injection Solution because the drug was found to be subpotent.
Cantrell Drug Company is recalling 450 syringes of Lidocaine HCl 1% injection due to subpotent drug levels. The recall is voluntary and nationwide.